J Gynecol Oncol.
2025 Jan;36(1):e73. 10.3802/jgo.2025.36.e73.
CHIPOR, HORSE, and beyond: unraveling the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer
- Affiliations
-
- 1Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea
- KMID: 2565506
- DOI: http://doi.org/10.3802/jgo.2025.36.e73
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Chemotherapy for ovarian cancer
- Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
- Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
- Ten-year treatment outcomes of consolidation hyperthermic intraperitoneal chemotherapy for ovarian cancer (HIPEC-KOV-03R)
- Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study
